<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03759288</url>
  </required_header>
  <id_info>
    <org_study_id>3150-301-008</org_study_id>
    <nct_id>NCT03759288</nct_id>
  </id_info>
  <brief_title>An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease</brief_title>
  <official_title>A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I)
      and versus an active comparator (Stage 2) in participants with moderately to severely active
      CD and will include assessments of clinical response as demonstrated by improvement of
      symptoms and colonic mucosal appearance as observed on endoscopy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 7, 2018</start_date>
  <completion_date type="Anticipated">December 4, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 4, 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stage 1. Percentage of participants with endoscopic response and clinical remission at Week 12</measure>
    <time_frame>12 Weeks</time_frame>
    <description>Endoscopic response based on decrease from baseline in Simple Endoscopic Score for Crohn's Disease (SES-CD)
Clinical remission based on average daily LSF (Loose Stool Frequency) and average daily AP (abdominal pain) score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stage 2. Percentage of participants with endoscopic response and clinical remission at Week 52</measure>
    <time_frame>52 Weeks</time_frame>
    <description>Endoscopic response based on decrease from baseline in Simple Endoscopic Score for Crohn's Disease(SES-CD).
Clinical remission based on average daily LSF (Loose Stool Frequency) and average daily AP (abdominal pain) score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stage 1. Percentage of participants with endoscopic response and clinical remission at both Weeks 12 and 52</measure>
    <time_frame>Up to 52 Weeks</time_frame>
    <description>Endoscopic response based on decrease from baseline in Simple Endoscopic Score for Crohn's Disease (SES-CD).
Clinical remission based on average daily LSF (Loose Stool Frequency) and average daily AP (abdominal pain) score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stage 1. Percentage of participants with endoscopic remission and clinical remission at Week 52</measure>
    <time_frame>52 Weeks</time_frame>
    <description>Endoscopic remission based on decrease from baseline in Simple Endoscopic Score for Crohn's Disease (SES-CD).
Clinical remission based on average daily LSF (Loose Stool Frequency) and average daily AP (abdominal pain) score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stage 1. Percentage of participants with endoscopic response at Week 12 and endoscopic remission at Week 52 and clinical remission at both Weeks 12 and 52</measure>
    <time_frame>Up to 52 Weeks</time_frame>
    <description>Endoscopic response and remission based on decrease from baseline in Simple Endoscopic Score for Crohn's Disease (SESCD).
Clinical remission based on average daily LSF (Loose Stool Frequency) and average daily AP (abdominal pain) score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stage 2. Percentage of participants with endoscopic response and clinical remission at both Weeks 12 and 52</measure>
    <time_frame>Up to 52 Weeks</time_frame>
    <description>Endoscopic response based on decrease from baseline in Simple Endoscopic Score for Crohn's Disease (SES-CD).
Clinical remission based on average daily LSF (Loose Stool Frequency) and average daily AP (abdominal pain) score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stage 2. Percentage of participants with endoscopic remission and clinical remission at Week 52</measure>
    <time_frame>52 Weeks</time_frame>
    <description>Endoscopic remission based on decrease from baseline in Simple Endoscopic Score for Crohn's Disease (SES-CD).
Clinical remission based on average daily LSF (Loose Stool Frequency) and average daily AP (abdominal pain) score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stage 2. Percentage of participants with corticosteriod-free endoscopic remission and clinical remission at Week 52</measure>
    <time_frame>52 Weeks</time_frame>
    <description>Endoscopic remission based on decrease from baseline in Simple Endoscopic Score for Crohn's Disease (SES-CD).
Clinical remission based on average daily LSF (Loose Stool Frequency) and average daily AP (abdominal pain) score</description>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Anticipated">1140</enrollment>
  <condition>Crohn's Disease</condition>
  <condition>IBD</condition>
  <arm_group>
    <arm_group_label>(Stage 1) Brazikumab high dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous Brazikumab on Day 85 and every 4 weeks through Week 48</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(Stage 1) Brazikumab low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous brazikumab on Day 85 and every 4 weeks through Week 48</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(Stage 1) Humira®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subcutaneous Humira® on Day 1, Day 15, Day 29 and every 2 weeks through Week 50</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(Stage 1) Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intravenous placebo on Days 1, 29, and 57, followed by subcutaneous placebo on Day 85 and every 2 weeks through Week 50</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(Stage 2) Brazikumab high dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous Brazikumab on Day 85 and every 4 weeks through Week 48</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(Stage 2) Brazikumab low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous Brazikumab 240 on Day 85 and every 4 weeks through Week 48</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(Stage 2) Humira®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subcutaneous Humira® on Day 1, Day 15, Day 29 and every 2 weeks through Week 50</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Brazikumab low dose</intervention_name>
    <description>Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous brazikumab on Day 85 and every 4 weeks through Week 48</description>
    <arm_group_label>(Stage 1) Brazikumab low dose</arm_group_label>
    <arm_group_label>(Stage 2) Brazikumab low dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Brazikumab high dose</intervention_name>
    <description>Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous brazikumab on Day 85 and every 4 weeks through Week 48</description>
    <arm_group_label>(Stage 1) Brazikumab high dose</arm_group_label>
    <arm_group_label>(Stage 2) Brazikumab high dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Humira®</intervention_name>
    <description>Administered subcutaneously on Day 1, Day 15, and Day 29 and every 2 weeks through Week 50.</description>
    <arm_group_label>(Stage 1) Humira®</arm_group_label>
    <arm_group_label>(Stage 2) Humira®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Intravenous placebo on Days 1, 29, 57 followed by subcutaneous placebo on Day 85 and every 2 weeks through Week 50</description>
    <arm_group_label>(Stage 1) Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion and Exclusion Criteria are the same for both Stage 1 and Stage 2; however,
        participants enrolled in Stage 1 will not be permitted to enroll in Stage 2.

        Inclusion Criteria:

          -  Aged 16 to 80 years, inclusive, at Screening. For participants less than 18 years of
             age, the participant must weigh at least 40 kg

          -  Diagnosis of ileal, ileocolonic, or colonic CD with an onset of symptoms for a minimum
             of 3 months prior to screening

          -  Moderately to severely active Crohn's Disease

        Exclusion Criteria:

          -  Participant is unable or unwilling to have endoscopic procedures performed during the
             study.

          -  History or current diagnosis of ulcerative colitis, indeterminate colitis, microscopic
             colitis, ischemic colitis, colonic mucosal dysplasia, primary sclerosing cholangitis,
             or untreated bile acid malabsorption.

          -  Any intra-abdominal surgery, bowel resection, diversion, placement of ostomy or stoma
             within 3 months prior to screening.

          -  Participant has known history of drug (including opiates) or alcohol abuse.

          -  Currently enrolled in another investigational device or drug study.

          -  Participant is pregnant, breastfeeding, or plans to become pregnant during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aparna Sahoo, DO</last_name>
    <role>Study Director</role>
    <affiliation>Allergan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Trial Registry Team</last_name>
    <phone>877-277-8566</phone>
    <email>IR-CTRegistration@Allergan.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shapiro Michael S MD</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Applied Research Center of Arkansas</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ventura Gastroenterolgy Medical Group</name>
      <address>
        <city>Camarillo</city>
        <state>California</state>
        <zip>93012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>eStudySite</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91911</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>619-955-5246</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>VVCRD Research</name>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Om Research LLC</name>
      <address>
        <city>Lancaster</city>
        <state>California</state>
        <zip>93534</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>661-388-2239</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Trials Research</name>
      <address>
        <city>Lincoln</city>
        <state>California</state>
        <zip>95648</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>916-434-8230</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>United Medical Doctors</name>
      <address>
        <city>Los Alamitos</city>
        <state>California</state>
        <zip>90720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gastrointestinal Biosciences</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Trials Specialist</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>ACRC Studies</name>
      <address>
        <city>Poway</city>
        <state>California</state>
        <zip>92064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Breakthrough Clinical Trials, LLC</name>
      <address>
        <city>San Bernardino</city>
        <state>California</state>
        <zip>92408</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Clinical Applications Laboratories, Inc</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lomita Family Medical Group, Inc</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Peak Gastroenterology Associates</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>719-636-1201</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Plasma Med Research</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33487</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Consultants of Clearwater</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>727-827-7685</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Top Medical Research</name>
      <address>
        <city>Cutler Bay</city>
        <state>Florida</state>
        <zip>33189</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-971-6883</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prohealth Research Center</name>
      <address>
        <city>Doral</city>
        <state>Florida</state>
        <zip>33166</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wellness Clinical Research</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>786-483-7856</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SIH Research</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>C&amp;R Research Services USA</name>
      <address>
        <city>Lake Worth</city>
        <state>Florida</state>
        <zip>33461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Auzmer Research</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>863-450-2580</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanchez Clinical Research, Inc</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-234-9484</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Professional Clinical Research Center, INC.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>786-801-1360</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Research, Inc</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34653</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sensible Healthcare</name>
      <address>
        <city>Ocoee</city>
        <state>Florida</state>
        <zip>34761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Advanced Research Institute, Inc.</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>727-835-3261</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guardian Angel Research Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gastro Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33762</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Atlanta Center for Gastroenterology and Atlanta Endoscopy Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Agile Clinical Research Trials</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30328</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Atlanta Gastroenterology Specialists</name>
      <address>
        <city>Suwanee</city>
        <state>Georgia</state>
        <zip>30024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Northwest Gastroenterology Group</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Illinois Gastroenterology Group, LLC</name>
      <address>
        <city>Gurnee</city>
        <state>Illinois</state>
        <zip>60031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Investigators Research Group, LLC</name>
      <address>
        <city>Brownsburg</city>
        <state>Indiana</state>
        <zip>46112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Aquaint Research</name>
      <address>
        <city>New Albany</city>
        <state>Indiana</state>
        <zip>47150</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>913-410-2831</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ideal Health</name>
      <address>
        <city>Shawnee Mission</city>
        <state>Kansas</state>
        <zip>66226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kansas Medical Clinic</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>785-354-8518</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tandem Clinical Research</name>
      <address>
        <city>Marrero</city>
        <state>Louisiana</state>
        <zip>70072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Capital Research</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Clinical Research Institute of Michigan</name>
      <address>
        <city>Chesterfield</city>
        <state>Michigan</state>
        <zip>48047</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Detroit Clinical Research Center</name>
      <address>
        <city>Farmington Hills</city>
        <state>Michigan</state>
        <zip>48334</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gen 1 Research - National Diabetes and Obesity Research Institute</name>
      <address>
        <city>Biloxi</city>
        <state>Mississippi</state>
        <zip>35932</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US / McGill Family Practice</name>
      <address>
        <city>Papillion</city>
        <state>Nebraska</state>
        <zip>68048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>402-819-7007</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jubilee Clinical Research</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Advanced Biomedical Research of America</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lovelace Scientific Resources, Inc.</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>505-348-9500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Trialspark</name>
      <address>
        <city>Astoria</city>
        <state>New York</state>
        <zip>11104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Trialspark, Inc.</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Trialspark, Inc.</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Manhattan Medical Research</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Manhattan Medical Research</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Trialspark</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Lucas Research</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Great Lakes Medical Research, LLC</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Inquest Center</name>
      <address>
        <city>Springfield</city>
        <state>Ohio</state>
        <zip>45503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Central Sooner Research</name>
      <address>
        <city>Norman</city>
        <state>Oklahoma</state>
        <zip>73071</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Digestive Disease Specialists (DDSI)</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fontier Clinical Research, LLC</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <zip>15401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>724-220-5281</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US/Primary Care Associates</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research, Inc</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>68048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US - Greer</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>East Tennessee Research Institute</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>GIA Clinical Trials</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>PharmaTex Research</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mesa Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78750</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>ClinRX Research Joseph INC</name>
      <address>
        <city>Carrollton</city>
        <state>Texas</state>
        <zip>75007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Vilo Research Group</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>832-660-5095</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sensible Healthcare</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77058</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>281-282-0808</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>DCT-McAllen Primary Care DBA Discovery Clinical Trials</name>
      <address>
        <city>McAllen</city>
        <state>Texas</state>
        <zip>78503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>DCT-AACT DBA Discovery Clinical Trials</name>
      <address>
        <city>Pflugerville</city>
        <state>Texas</state>
        <zip>78660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gastroenterology of San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>DCT Stone Oak DBA Discovery Clinical Trials</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>210-764-4842</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Research Institute</name>
      <address>
        <city>South Ogden</city>
        <state>Utah</state>
        <zip>84405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>801-409-2040</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Research Partners</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toronto Digestive Disease Associates Inc</name>
      <address>
        <city>Vaughan</city>
        <state>Ontario</state>
        <zip>L4L 4Y7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fundación de Investigación de Diego</name>
      <address>
        <city>San Juan</city>
        <zip>00927</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 20, 2018</study_first_submitted>
  <study_first_submitted_qc>November 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2018</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adalimumab</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

